Javier Rodriguez - 14 May 2022 Form 4 Insider Report for BioXcel Therapeutics, Inc. (BTAI)

Role: Chief Legal Officer, Senior Vice President and Secretary
Signature: /s/ Richard I. Steinhart, as Attorney-in-Fact for Javier Rodriguez
Issuer symbol: BTAI
Transactions as of: 14 May 2022
Net transactions value: $0
Form type: 4
Filing time: 17 May 2022, 15:38:25 UTC
Previous filing: 16 Mar 2022
Next filing: 16 Mar 2023
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	BTAI	Restricted Stock Units	Award	$0	+5,000		$0.000000	5,000	14 May 2022	Common Stock	5,000		Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs will vest and settle on May 14, 2023, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates.

Remarks:

Chief Legal Officer, Senior Vice President and Secretary